Early contributors to the success of anti-COVID vaccines
The paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’ [1]. This short commentary highlights some early events that were to underpin the success of a new anti-COV...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-12-01
|
| Series: | Medicine in Drug Discovery |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098621000269 |
| Summary: | The paper of Gregory Gregoriadis brings into sharp relief the contrast in time taken for ‘individual technologies to emerge from research, find market opportunities and make a tangible impact’ [1]. This short commentary highlights some early events that were to underpin the success of a new anti-COVID vaccine. |
|---|---|
| ISSN: | 2590-0986 |